Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine

被引：15

作者：

Cohen, Olivia G. ^{[1
]}

Clark, Ashley K. ^{[1
]}

Milbar, Heather ^{[1
]}

Tarlow, Mordechai ^{[2
]}

机构：

[1] Univ Penn, Dept Dermatol, Philadelphia, PA 19104 USA

[2] Adv Dermatol & Skin Surg PC, Lakewood, NJ USA

来源：

HUMAN VACCINES & IMMUNOTHERAPEUTICS | 2021年 / 17卷 / 11期

关键词：

Vaccination; COVID-19; pityriasis rosea;

D O I：

10.1080/21645515.2021.1963173

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 ; 0836 ; 090102 ; 100705 ;

摘要：

Pityriasis rosea (PR) is an acute papulosquamous cutaneous disorder that classically presents with a herald patch rapidly followed by a widespread rash along skin cleavage lines. Although the exact pathogenesis of PR is unknown, current evidence suggests that an inflammatory reaction due to a viral trigger may lead to the cutaneous manifestations. COVID-19 has been reported as one such viral trigger for PR. Previously, PR has been reported in temporal association with various viral inoculations. This article presents a case of PR in a 66-year-old black male 1 week after administration of the Pfizer-BioNTech COVID-19 vaccine.

引用

页码：4097 / 4098

页数：2

共 50 条

[31] Comment on "Tachycardia following Pfizer-BioNTech COVID-19 vaccine"
Mungmunpuntipantip, Rujittika
Wiwanitkit, Viroj
[J]. ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA, 2023, 41 (01): : 63 - 63
[32] Pfizer-BioNTech and Moderna Lead the COVID-19 Vaccine Race
不详
[J]. CHEMICAL ENGINEERING PROGRESS, 2021, 117 (02) : 9 - 9
[33] Pityriasis Rosea Following Pfizer-BioNTech Vaccination in an Adolescent Girl
Rubaian, Nouf F. Bin
Almuhaidib, Seereen R.
Aljarri, Shadan A.
Alamri, Areen S.
[J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (07)
[34] A panty rosea-like eruption following the second Pfizer-BioNTech COVID-19 vaccine administration dose in a pediatric patient
Russo, Antonio
Benati, Mattia
Roncati, Luca
Zengarini, Corrado
Neri, Iria
[J]. ITALIAN JOURNAL OF DERMATOLOGY AND VENEREOLOGY, 2023, 158 (06) : 497 - 498
[35] First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Havla, Joachim
Schultz, Yannick
Zimmermann, Hanna
Hohlfeld, Reinhard
Danek, Adrian
Kumpfel, Tania
[J]. JOURNAL OF NEUROLOGY, 2022, 269 (01) : 55 - 58
[36] Nursing home resident deaths after Pfizer-BioNTech's COVID-19 vaccine
[J]. Reactions Weekly, 2021, 1859 (1) : 7 - 7
[37] COVID-19 Vaccine Uptake and Intentions Following US Food and Drug Administration Approval of the Pfizer-BioNTech COVID-19 Vaccine
Scherer, Aaron M.
Parker, Andrew M.
Gidengil, Courtney A.
Gedlinske, Amber M.
Askelson, Natoshia M.
Petersen, Christine A.
Lindley, Megan C.
[J]. JAMA INTERNAL MEDICINE, 2022, 182 (06) : 678 - 680
[38] Eczematiform eruption after Pfizer-BioNTech COVID-19 vaccineMots
Bekkali, Nihal
Allard, Tanguy
Lengelle, Celine
Esteve, Eric
[J]. THERAPIE, 2021, 76 (04): : 364 - 365
[39] First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine
Joachim Havla
Yannick Schultz
Hanna Zimmermann
Reinhard Hohlfeld
Adrian Danek
Tania Kümpfel
[J]. Journal of Neurology, 2022, 269 : 55 - 58
[40] Fixed drug eruption after Pfizer-BioNTech COVID-19 vaccine: A case report
Lellig, Elodie
Mouton-Faivre, Claudie
Abs, Diane
Bursztejn, Anne-Claire
[J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (07): : 1922 - 1923

← 1 2 3 4 5 →